Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

Nature Medicine's publication of a multimodal explainable AI decision‑support tool that outperformed established biomarkers for immunotherapy outcome prediction in non‑small cell lung cancer signals a rapid move toward AI‑driven clinical recommendations being embedded in web‑based health platforms. For website owners of medical information sites, oncology forums, or patient‑support portals, this breakthrough means AI crawlers—especially those operated by pharma partners, research institutions, and emerging health‑tech startups—will increasingly seek to index detailed study data, model explanations, and outcome dashboards. These bots will request structured data (e.g., JSON‑LD clinical trial results) and may attempt to interact with interactive decision‑support widgets embedded on pages. If not properly identified, such traffic can inflate analytics, trigger rate‑limiting, or expose proprietary content to unvetted AI services. **Actionable tips:** 1. **Update your llms.txt** to explicitly allow reputable health‑AI crawlers (e.g., `User‑Agent: HealthAI/1.0` `Allow: /research/*`) while disallowing generic large‑language‑model scrapers that could misuse patient data. 2. **Implement bot‑fingerprinting** using request headers and behavior patterns to differentiate genuine research bots from generic web scrapers, then route them to a lightweight API that serves only the necessary study metadata. 3. **Monitor AI‑specific traffic** in your analytics dashboard, flagging spikes in `/research/` or `/datasets/` endpoints, and set up alerts to adjust rate limits or update llms.txt permissions as new AI models emerge.